Concepedia

Megan S. Lim

MS

142

Publications

11.9K

Citations

56

H-Index

1985

Active since

Affiliations

University of Michigan(Current)

University of Utah

University of Pennsylvania

ARUP Laboratories (United States)

ARUP Institute for Clinical and Experimental Pathology

Megan S. Lim is an author at University of Michigan specializing in medicine, pathology, and cell biology.

ORCID

Top concepts

Publications per year

1985–2025

142

Publications

142

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

Yaël P. Mossé, Megan S. Lim, Stephan D. Voss et al. · The Lancet Oncology · 2013 · 686 citations · Full text

, , +8

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg et al. · Blood · 2017 · 590 citations · Full text

Skp2 is oncogenic and overexpressed in human cancers

Matthias Gstaiger, Richard C. Jordan, Megan S. Lim et al. · Proceedings of the National Academy of Sciences · 2001 · 501 citations · Full text

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study

Yaël P. Mossé, Stephan D. Voss, Megan S. Lim et al. · Journal of Clinical Oncology · 2017 · 396 citations · Full text

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Frits van Rhee, Peter M. Voorhees, Angela Dispenzieri et al. · Blood · 2018 · 394 citations · Full text

Rows per page

1–5 of 142